Christopher Klein Rvl Pharmaceuticals PLC (RVLP) insider trading activity

Christopher Klein is General Counsel & Secretary of RVL Pharmaceuticals plc. Currently has a direct ownership of 180,573 shares of RVLP, which is worth approximately $0. The most recent transaction as insider was on May 18, 2023, when has been sold 5,447 shares (Ordinary Shares) at a price of $0.87 per share, resulting in proceeds of $4,738. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 181K

0% 3M change

0% 12M change

Total Value Held $0

Christopher Klein Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 18 2023	SELL Payment of exercise price or tax liability	$4,738 $0.87 p/Share	5,447 Reduced 2.93%	180,573 Ordinary Shares
Jan 24 2023	SELL Payment of exercise price or tax liability	$12,106 $1.26 p/Share	9,608 Reduced 4.91%	186,020 Ordinary Shares
May 18 2022	SELL Payment of exercise price or tax liability	$8,578 $1.4 p/Share	6,127 Reduced 3.04%	195,628 Ordinary Shares
Jan 24 2022	SELL Payment of exercise price or tax liability	$10,856 $1.13 p/Share	9,607 Reduced 4.55%	201,755 Ordinary Shares
May 18 2021	SELL Payment of exercise price or tax liability	$20,177 $3.12 p/Share	6,467 Reduced 2.97%	211,362 Ordinary Shares
Jan 24 2021	SELL Payment of exercise price or tax liability	$42,838 $4.46 p/Share	9,605 Reduced 4.22%	217,829 Ordinary Shares

Christopher Klein

General Counsel & Secretary

Bridgewater, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RVLP shares.

Notify only if

Value

Insider Trading

Get notified when an Rvl Pharmaceuticals PLC insider buys or sells RVLP shares.

Notify only if

Operation

Value

Type

News

Receive news related to RVL Pharmaceuticals plc

Track Activities on RVLP

Account